{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:06:52Z","timestamp":1782122812259,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ijrobp.2022.05.009","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T18:39:03Z","timestamp":1652726343000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3468-3359","authenticated-orcid":false,"given":"Brian","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey L.","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan B.","family":"Ludmir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cullen M.","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Minsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J.","family":"Koay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Koong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van K.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Messick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Nancy","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Lenaine","family":"Westney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela M.","family":"Nogueras Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma B.","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.05.009_bib0001","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2\u00a0\u00d7\u00a02 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0002","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0003","unstructured":"National Comprehensive Cancer Network. National Comprehensive Cancer Network clinical practice guidelines in oncology: Anal carcinoma (2.2021). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/anal.pdf. Accessed September 1, 2021."},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0005","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/0284186X.2018.1503713","article-title":"Late gastrointestinal toxicity after radiotherapy for anal cancer: A systematic literature review","volume":"57","author":"Pan","year":"2018","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0006","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijrobp.2021.08.008","article-title":"Long-term outcomes of NRG Oncology\/RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in anal canal cancer","volume":"112","author":"Kachnic","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0007","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.radonc.2018.06.006","article-title":"Prospective evaluation of acute toxicity and patient reported outcomes in anal cancer and plan optimization","volume":"128","author":"Kronborg","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0008","first-page":"3613","article-title":"Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy","volume":"23","author":"Sodergren","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0009","first-page":"1","article-title":"Quality of life after radiotherapy for rectal and anal cancer","volume":"16","author":"Neibart","year":"2020","journal-title":"Curr Colorectal Cancer Rep"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijrobp.2020.12.007","article-title":"Analysis of patient-reported outcome utilization within National Clinical Trials Network Cooperative Group Radiation Oncology trials over the past 2 decades","volume":"109","author":"Howell","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0011","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0012","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/annonc\/mds539","article-title":"The FACT-G7: A rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research","volume":"24","author":"Yanez","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02237236","article-title":"Fecal incontinence quality of life scale","volume":"43","author":"Rockwood","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0014","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/codi.12952","article-title":"Validation of the English translation of the low anterior resection syndrome score","volume":"17","author":"Juul","year":"2015","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamasurg.2018.3752","article-title":"Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: The CARTS study","volume":"154","author":"Stijns","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0016","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2018.11.017","article-title":"Impact of radiotherapy on anorectal function in patients with rectal cancer following a watch and wait programme","volume":"132","author":"van der Sande","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0017","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0022-5347(05)66926-1","article-title":"Scoring the short form ICSmaleSF questionnaire","volume":"164","author":"Donovan","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0018","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ajog.2003.12.027","article-title":"A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: Data from a randomized controlled trial of surgery for women with stress incontinence","volume":"191","author":"Brookes","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0019","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/cncr.28758","article-title":"Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy","volume":"120","author":"Pearman","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3393\/ac.2015.31.1.23","article-title":"Predictors of fecal incontinence and related quality of life after a total mesorectal excision with primary anastomosis for patients with rectal cancer","volume":"31","author":"Walma","year":"2015","journal-title":"Ann Coloproctol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0021","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","article-title":"Low anterior resection syndrome score: Development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer","volume":"255","author":"Emmertsen","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0022","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/nau.23986","article-title":"Patient-reported outcomes and urodynamic findings in men with persistent lower urinary tract symptoms following robot-assisted radical prostatectomy","volume":"38","author":"MacKenzie","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0023","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1002\/cncr.28296","article-title":"Long\u2010term results of weekly\/daily cisplatin\u2010based chemoradiation for locally advanced squamous cell carcinoma of the anal canal","volume":"119","author":"Eng","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0024","series-title":"Common terminology criteria for adverse events: (CTCAE)","year":"2010"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0025","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0026","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: An extension to the PRISMA statement for reporting literature searches in Systematic Reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0027","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00192-015-2626-8","article-title":"Prevalence, risk factors and the bother of lower urinary tract symptoms in China: A population-based survey","volume":"26","author":"Wang","year":"2015","journal-title":"Int Urogynecol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0028","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/codi.15541","article-title":"Urinary dysfunction after colorectal cancer treatment and its impact on quality of life\u2014A national cross-sectional study in women","volume":"23","author":"Sinim\u00e4ki","year":"2021","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0029","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/codi.15554","article-title":"Urinary dysfunction after colorectal cancer treatment and impact on quality of life\u2014A national cross-sectional study in males","volume":"23","author":"Kristensen","year":"2021","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0030","first-page":"7249","article-title":"The incidence and risk factors of low anterior resection syndrome (LARS) after sphincter-preserving surgery of rectal cancer: A systematic review and meta-analysis","volume":"29","author":"Sun","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0031","first-page":"340","article-title":"Better quality of life and reduced fecal incontinence in rectal cancer patients with the watch-and-wait follow-up strategy","volume":"86","author":"Pascual-Russo","year":"2021","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0032","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00384-019-03249-7","article-title":"To what extent is the low anterior resection syndrome (LARS) associated with quality of life as measured using the EORTC C30 and CR38 quality of life questionnaires?","volume":"34","author":"Kupsch","year":"2019","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0033","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11136-017-1700-8","article-title":"Prevalence of patient-reported gastrointestinal symptoms and agreement with clinician toxicity assessments in radiation therapy for anal cancer","volume":"27","author":"Tom","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0034","doi-asserted-by":"crossref","first-page":"e1524","DOI":"10.1200\/OP.20.00122","article-title":"Patient-reported GI outcomes in patients with anal cancer receiving modern chemoradiation","volume":"16","author":"Kouzy","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2019.12.022","article-title":"UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes","volume":"128","author":"Gilbert","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0036","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2014.06.061","article-title":"Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer","volume":"90","author":"Han","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0037","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/codi.15590","article-title":"Long-term bowel function patient-reported outcomes after successful chemoradiation for carcinoma of the anal canal","volume":"23","author":"Shaw","year":"2021","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0038","first-page":"4169","article-title":"Patient-reported QoL in anal cancer survivors 3 and 6 years after treatment-results from the Swedish national ANCA study","volume":"30","author":"Axelsson","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0039","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jnci\/djab178","article-title":"How vital are patient-reported outcomes?","volume":"114","author":"Chang","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0040","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ijrobp.2021.11.024","article-title":"Association between physician- and patient-reported symptoms in patients treated with definitive radiation therapy for locally advanced lung cancer in a statewide consortium","volume":"112","author":"Wilkie","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0041","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijrobp.2020.06.030","article-title":"Characteristics of participation in patient-reported outcomes and electronic data capture components of NRG Oncology Clinical Trials","volume":"108","author":"Pugh","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0042","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0043","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jclinepi.2009.05.001","article-title":"Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G","volume":"63","author":"King","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0044","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/nau.24614","article-title":"Predicting response to a community-based educational workshop on incontinence among community-dwelling older women: Post hoc analysis of the CACTUS-D trial","volume":"40","author":"Fritel","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2017.02.005","article-title":"Predictors of radiation therapy-related gastrointestinal toxicity from anal cancer dose-painted intensity modulated radiation therapy: Secondary analysis of NRG Oncology RTOG 0529","volume":"98","author":"Olsen","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0046","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.clon.2015.08.006","article-title":"Implementing intensity-modulated radiotherapy with simultaneous integrated boost for anal cancer: 3 year outcomes at two Sydney institutions","volume":"27","author":"Yates","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0047","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.clon.2018.07.020","article-title":"Intensity-modulated radiotherapy for anal cancer: Dose-volume relationship of acute gastrointestinal toxicity and disease outcomes","volume":"30","author":"Ng","year":"2018","journal-title":"Clinical Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000348387","article-title":"Dosimetric parameters predictive of acute gastrointestinal toxicity in patients with anal carcinoma treated with concurrent chemotherapy and intensity-modulated radiation therapy","volume":"85","author":"DeFoe","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0049","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.radonc.2009.07.006","article-title":"A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy","volume":"93","author":"Devisetty","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0050","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.clon.2021.09.011","article-title":"Dosimetric and clinical predictors for acute and late gastrointestinal toxicity following chemoradiotherapy of locally advanced anal cancer","volume":"34","author":"Nilsson","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0051","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0300891618811273","article-title":"Chemoradiation in female patients with anal cancer: Patient-reported outcome of acute and chronic side effects","volume":"105","author":"Koerber","year":"2019","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0052","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00384-019-03342-x","article-title":"Quality of life in patients treated for anal carcinoma\u2014A systematic literature review","volume":"34","author":"Sterner","year":"2019","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0053","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1053\/j.gastro.2017.08.018","article-title":"Racial disparity in gastrointestinal cancer risk","volume":"153","author":"Ashktorab","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0054","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/jnci\/dji163","article-title":"Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study","volume":"97","author":"Chin-Hong","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13014-018-1124-9","article-title":"Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study","volume":"13","author":"Franco","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0056","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ijrobp.2019.06.2544","article-title":"Executive Summary of the American Radium Society appropriate use criteria for treatment of anal cancer","volume":"105","author":"Russo","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.05.009_bib0057","unstructured":"Group E-ACR. Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE study. Available at: https:\/\/ClinicalTrials.gov\/show\/NCT04166318. Accessed February 15, 2022."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622004175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622004175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:00:51Z","timestamp":1759744851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622004175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0360301622004175"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.05.009","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}